IDEXX Options Shift Toward Defense Before Monday's Print

IDXX fell 4.3% on Friday to $551.21, a sharper drop than the week's median move for its closest peers, most of which closed flat to modestly higher. That single-session loss has pushed the put/call ratio to 0.58, well above its 20-day average of 0.46 and roughly 1.5 standard deviations elevated. Options buyers have been tilting toward protection consistently since mid-October, when the PCR sat near its 52-week low of 0.35. The shift is notable in the context of a stock already down 18% year-to-date: investors are paying more for downside cover on a name that has already given back a significant amount.

The borrow market tells a quieter story. Short interest is low at 2.4% of the free float, and availability is extraordinarily loose at roughly 4,470%, meaning shares to borrow outnumber those already borrowed by more than 40 to one. Cost to borrow has doubled over the past week to 0.55%, but that doubling is from a near-zero base and the absolute level remains negligible. Shorts are not driving the narrative here.

Analyst sentiment has frayed at the edges ahead of the report. UBS trimmed its target from $670 to $627 on October 27, maintaining a Neutral rating. JP Morgan also lowered its target earlier in the month, to $750 from $775, while keeping an Overweight. BTIG suspended coverage entirely on Friday, the same day as the selloff. The consensus mean target of $694 implies roughly 26% upside from current levels, a gap that reflects the Street's continued faith in IDEXX's recurring-revenue model and the structural "humanization of pets" tailwind. Bears point to supply chain risk and the weight of a 35x price-to-earnings multiple on a business whose forward earnings growth ranks only in the 26th percentile of its universe. The EV/EBITDA of 25x has expanded over the past 30 days even as the share price drifted, because earnings estimates have been revised downward faster than the stock has fallen.

Wikipedia page views for IDXX registered a z-score of 2.3 against the company's own 90-day history as of October 19, a measure of retail attention that has climbed to its highest relative level in the tracked period. That spike in attention coincides with the stock's sharp October move and the analyst activity around it. It is a measure of interest, not a revenue signal, but the timing suggests new retail participants are engaging with the name ahead of Monday's release.

The most recent earnings history shows the stock fell 3.4% on the day and a further 4.3% over the following week after the August 2026 print. The prior event in that same month produced a 1% gain on the day but a 6.6% five-day loss. The pattern of muted-to-negative post-earnings drifts over recent quarters means Monday's report is less a test of whether IDEXX can beat consensus and more a question of whether the company can provide a forward outlook that justifies paying a premium multiple when earnings-estimate momentum sits at the 50th percentile of the market.